Skip to main content
Smart Investors Daily
SA

OTC · SAEYY

Redcare Pharmacy N.V.

Healthcare · Medical - Pharmaceuticals

$8.09

Up+$0.00 (+0.00%)

Updated Nov 5, 2026, 4:27 PM

SID Score

5.3/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.51B
P/E ratio
-36.54
Dividend yield
0.00%
52-week range
— – —
Volume
1
Avg. volume
257

Price performance · SAEYY

SAEYY price history

1M range · 0 trading sessions · Daily adjusted prices

SAEYY does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest SAEYY news

The latest Smart Investors Daily articles mentioning SAEYY.

SAEYY research

Overview

Company profile and research snapshot.

Company profile

REDCARE PHAMACY UNSP/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$105.47
Implied upside
—
Analysts
15
SAEYY recent ratings
DateFirmRatingTarget
Sep 21, 2026BERENBERGBuy—
Sep 3, 2026JEFFERIESBuy—
Aug 31, 2026CANTOR FITZGERALDOverweight—
Aug 28, 2026METZLER EQUITIESBuy—
Jul 31, 2026WARBURG RESEARCH GMBHBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 17, 2026

Redcare Pharmacy (XTRA:RDC) Stock May Be Priced Richly After A 47% Five Year Fall

Redcare Pharmacy has seen sharp swings in recent years, and the question now is whether the current share price around €74.80 is properly backed by what its sales can justify. After a long stretch of weak long term returns followed by a burst of shorter term gains, investors are again asking what they are really paying for in terms of revenue. Over the past 5 years the stock has fallen 46.6%, which puts the focus squarely on whether the business that produced those sales is now being priced...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.